Elevated CA125 levels in patients with metastatic breast carcinoma.
作者信息
Perey L, Hayes D F, Tondini C, van Melle G, Bauer J, Lemarchand T, Reymond M, Mach J P, Leyvraz S
机构信息
Service d'Oncologie, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
出版信息
Br J Cancer. 1990 Oct;62(4):668-70. doi: 10.1038/bjc.1990.353.
Abstract
摘要
相似文献
1
Elevated CA125 levels in patients with metastatic breast carcinoma.转移性乳腺癌患者CA125水平升高。
Br J Cancer. 1990 Oct;62(4):668-70. doi: 10.1038/bjc.1990.353.
2
Follow-up of metastatic breast cancer patients with a mucin-like carcinoma-associated antigen: comparison to CA 15.3 and carcinoembryonic antigen.对黏蛋白样癌相关抗原检测的转移性乳腺癌患者的随访：与CA 15.3和癌胚抗原的比较
Cancer Lett. 1988 Nov;42(3):199-206. doi: 10.1016/0304-3835(88)90305-9.
3
[Mucoid carcinoma antigen--a new tumor marker].[黏液样癌抗原——一种新的肿瘤标志物]
Gynakol Rundsch. 1988;28 Suppl 2:203-5.
4
5
[The expression of NCC-ST-439, a tumor marker, in human breast cancer patients].[肿瘤标志物NCC-ST-439在人类乳腺癌患者中的表达]
Gan No Rinsho. 1990 Sep;36(11):2023-6.
6
Serial measurements of Ca antigen in sera from patients with advanced malignant breast disease.晚期恶性乳腺疾病患者血清中钙抗原的系列测定。
Clin Chim Acta. 1990 Jan 31;186(3):351-8. doi: 10.1016/0009-8981(90)90321-i.
7
[CA 15-3 in the diagnosis and monitoring of carcinoma of the breast and its correlations with CEA].[癌胚抗原15-3在乳腺癌诊断、监测中的应用及其与癌胚抗原的相关性]
Minerva Chir. 1989 Mar 31;44(6):1015-20.
8
[CA 15.3, a marker of breast cancer].[癌抗原15.3，一种乳腺癌标志物]
Med Clin (Barc). 1988 Sep 24;91(9):341-3.
9
Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.乳腺癌患者循环CA15-3和癌胚抗原水平的比较。
J Clin Oncol. 1986 Oct;4(10):1542-50. doi: 10.1200/JCO.1986.4.10.1542.
10
[Use of radioimmunoanalysis of tumor markers in the diagnosis of carcinoma of the breast, ovary and intestines].[肿瘤标志物放射免疫分析在乳腺癌、卵巢癌和肠癌诊断中的应用]
Bratisl Lek Listy. 1988 Aug;89(8):563-76.
引用本文的文献
1
Mesorectum localization as a special kind of rectal metastasis from breast cancer.直肠系膜定位作为一种特殊类型的乳腺癌直肠转移。
World J Gastroenterol. 2015 Apr 14;21(14):4408-12. doi: 10.3748/wjg.v21.i14.4408.
2
Promoting quality and evidence-based care in early-stage breast cancer follow-up.促进早期乳腺癌随访中的质量和循证护理。
J Natl Cancer Inst. 2014 Apr;106(4):dju034. doi: 10.1093/jnci/dju034. Epub 2014 Mar 13.
3
Is an increase in CA 125 in breast cancer patients an indicator of pleural metastases?乳腺癌患者CA 125升高是否为胸膜转移的指标？
Br J Cancer. 1994 Sep;70(3):493-5. doi: 10.1038/bjc.1994.333.
4
CA-125 is not a useful marker in metastatic breast cancer.
Br J Cancer. 1992 Nov;66(5):875-6. doi: 10.1038/bjc.1992.377.
本文引用的文献
1
Reporting results of cancer treatment.癌症治疗结果报告。
Cancer. 1981 Jan 1;47(1):207-14. doi: 10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6.
2
Sandwich enzyme immunoassay using three monoclonal antibodies against different epitopes of carcinoembryonic antigen (CEA).使用三种针对癌胚抗原（CEA）不同表位的单克隆抗体的夹心酶免疫测定法。
Immunol Lett. 1982 Aug;5(2):85-91. doi: 10.1016/0165-2478(82)90038-4.
3
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.一种使用单克隆抗体监测上皮性卵巢癌病程的放射免疫分析。
N Engl J Med. 1983 Oct 13;309(15):883-7. doi: 10.1056/NEJM198310133091503.
4
Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker.卵巢癌抗原CA125：对其作为肿瘤标志物作用的前瞻性临床评估
Br J Cancer. 1984 Dec;50(6):765-9. doi: 10.1038/bjc.1984.254.
5
CA125 seric levels in non malignant pathologies.非恶性病变中的CA125血清水平。
Bull Cancer. 1984;71(2):145-6.
6
Value of CA 15:3 in the follow-up of breast cancer patients.CA 15:3在乳腺癌患者随访中的价值。
Br J Cancer. 1987 May;55(5):567-9. doi: 10.1038/bjc.1987.115.
7
Immunoradiometric assay of CA 125 in effusions. Comparison with carcinoembryonic antigen.积液中CA 125的免疫放射分析。与癌胚抗原的比较。
Cancer. 1987 Jan 15;59(2):218-22. doi: 10.1002/1097-0142(19870115)59:2<218::aid-cncr2820590207>3.0.co;2-0.
8
Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.胰腺癌中的肿瘤标志物抗原CA125：与CA19-9和癌胚抗原的比较
Br J Cancer. 1986 Dec;54(6):897-901. doi: 10.1038/bjc.1986.259.
9
10
Zotero 插件